| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.008 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.66 |
0.01 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |